1. Home
  2. BLLN vs MTG Comparison

BLLN vs MTG Comparison

Compare BLLN & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.23

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo MGIC Investment Corporation

MTG

MGIC Investment Corporation

SELL

Current Price

$27.03

Market Cap

5.6B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
BLLN
MTG
Founded
2016
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.6B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
BLLN
MTG
Price
$93.23
$27.03
Analyst Decision
Buy
Hold
Analyst Count
8
6
Target Price
★ $129.00
$31.40
AVG Volume (30 Days)
561.3K
★ 2.6M
Earning Date
08-05-2026
11-04-2026
Dividend Yield
N/A
★ 2.48%
EPS Growth
★ 103.40
8.65
EPS
0.48
★ 1.62
Revenue
$305,112,000.00
★ $1,213,636,000.00
Revenue This Year
$49.05
N/A
Revenue Next Year
$26.16
$1.04
P/E Ratio
$204.98
★ $16.92
Revenue Growth
★ 99.97
0.49
52 Week Low
$61.96
$24.69
52 Week High
$150.44
$31.89

Technical Indicators

Market Signals
Indicator
BLLN
MTG
Relative Strength Index (RSI) 38.68 37.08
Support Level $88.85 $25.48
Resistance Level $98.14 $27.35
Average True Range (ATR) 7.14 0.73
MACD -2.29 -0.01
Stochastic Oscillator 6.44 35.37

Price Performance

Historical Comparison
BLLN
MTG

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.

Share on Social Networks: